FRT
45
2
COF
47
-3
NTAP
46
3
ISRG
55
-2
HPE
63
4
URBN
54
4
ACN
22
6
ESS
33
2
AIG
45
-12
AAP
26
-7
INTC
61
5
MS
61
2
VRSN
66
4
CSCO
57
3
CNP
70
2
NDAQ
57
2
IFF
48
-2
KR
49
4
LNC
40
-2
FSLR
49
-3
FRT
45
2
COF
47
-3
NTAP
46
3
ISRG
55
-2
HPE
63
4
URBN
54
4
ACN
22
6
ESS
33
2
AIG
45
-12
AAP
26
-7
INTC
61
5
MS
61
2
VRSN
66
4
CSCO
57
3
CNP
70
2
NDAQ
57
2
IFF
48
-2
KR
49
4
LNC
40
-2
FSLR
49
-3
Financhill
Back

Arrow Long/Short Alternative Fund Series ETF Vs. Spyre Therapeutics, Inc. Industry Stock Comparison

Sell
34

ACAA.TO
Arrow Long/Short Alternative Fund Series ETF

Last Price:
$26.25
Seasonality Move:
0.98%
Buy
63

SYRE
Spyre Therapeutics, Inc.

Last Price:
$47.58
Seasonality Move:
-1.09%
Sell
34
Arrow Long/Short Alternative Fund Series ETF (ACAA.TO) is a Sell

Is Arrow Long/Short Alternative Fund Series ETF a Buy, Sell or Hold?

  • The current Arrow Long/Short Alternative Fund Series ETF [ACAA.TO] share price is $26.31. The Score for ACAA.TO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • ACAA.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Spyre Therapeutics, Inc. (SYRE) is a Buy

Is Spyre Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Spyre Therapeutics, Inc. [SYRE] share price is $47.58. The Score for SYRE is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • SYRE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ACAA.TO Stock Price Chart

What is Arrow Long/Short Alternative Fund Series ETF's stock price today?

  • The Arrow Long/Short Alternative Fund Series ETF share price today is $26.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ACAA.TO is experiencing slight buying pressure.

SYRE Stock Price Chart

What is Spyre Therapeutics, Inc.'s stock price today?

  • The Spyre Therapeutics, Inc. share price today is $47.58
    The current trend is moderately bullish and SYRE is experiencing slight buying pressure.

ACAA.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.85 Buy
Relative Strength Index (14 RSI): 55.81 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (25.82 - 26.4) Buy
Bollinger Bands (100): (24.18 - 26.02) Buy

SYRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.39 Buy
Relative Strength Index (14 RSI): 60.73 Buy
Chaikin Money Flow: 101552 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.42 - 46.32) Buy
Bollinger Bands (100): (28.36 - 41.52) Buy

ACAA.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 26.12 Buy
20-day SMA: 26.03 Buy
50-day SMA: 25.9 Buy
200-day SMA: 23.89 Buy
8-day EMA: 25.65 Buy
20-day EMA: 20.79 Buy
50-day EMA: 12.29 Buy
200-day EMA: 3.84 Buy

SYRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.88 Buy
20-day SMA: 43.85 Buy
50-day SMA: 39.64 Buy
200-day SMA: 26.25 Buy
8-day EMA: 46.92 Buy
20-day EMA: 44.54 Buy
50-day EMA: 40.51 Buy
200-day EMA: 30.19 Buy

Arrow Long/Short Alternative Fund Series ETF Earnings Growth & ACAA.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Spyre Therapeutics, Inc. Earnings Growth & SYRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.51 per share, a decrease this year of $0.72 per share, and a decrease next year of $0.16 per share.

Arrow Long/Short Alternative Fund Series ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Spyre Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):